Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

1.

Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?

Jakić M, Lovcić V, Klarić D, Mihaljević D, Zibar L, Jakić M, Marić I.

Coll Antropol. 2010 Mar;34 Suppl 1:181-8.

PMID:
20402316
[PubMed - indexed for MEDLINE]
2.

Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.

Siamopoulos KC, Elisaf MS, Bairaktari HT, Pappas MB, Sferopoulos GD, Nikolakakis NG.

Perit Dial Int. 1995 Oct-Dec;15(8):342-7.

PMID:
8785232
[PubMed - indexed for MEDLINE]
Free Article
3.

The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.

Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C.

J Ren Nutr. 2002 Jul;12(3):183-9.

PMID:
12105816
[PubMed - indexed for MEDLINE]
4.

Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men.

Denke MA, Sempos CT, Grundy SM.

Arch Intern Med. 1993 May 10;153(9):1093-103.

PMID:
8481076
[PubMed - indexed for MEDLINE]
5.

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.

PMID:
19167589
[PubMed - indexed for MEDLINE]
6.
8.

Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.

Yiğitoğlu MR, Polat MF, Akçay F, Ari Z, Uyanik BS, Ozilgili HM.

Jpn Heart J. 1997 Jan;38(1):83-9.

PMID:
9186284
[PubMed - indexed for MEDLINE]
9.

Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.

Desmeules S, Arcand-Bossé JF, Bergeron J, Douville P, Agharazii M.

Am J Kidney Dis. 2005 Jun;45(6):1067-72.

PMID:
15957136
[PubMed - indexed for MEDLINE]
10.

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.

Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9.

PMID:
11012570
[PubMed - indexed for MEDLINE]
11.

Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.

Ettinger WH, Wahl PW, Kuller LH, Bush TL, Tracy RP, Manolio TA, Borhani NO, Wong ND, O'Leary DH.

Circulation. 1992 Sep;86(3):858-69.

PMID:
1516198
[PubMed - indexed for MEDLINE]
12.

Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.

Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inoue T, Morii H.

Atherosclerosis. 1997 Jun;131(2):229-36.

PMID:
9199276
[PubMed - indexed for MEDLINE]
13.
14.

Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure.

Saltissi D, Westhuyzen J, Morgan C, Healy H.

Clin Exp Nephrol. 2006 Sep;10(3):201-9.

PMID:
17009078
[PubMed - indexed for MEDLINE]
15.

Serum lipid profile of Nigerian diabetics with end stage renal disease.

Agaba EI, Duguru M, Agaba PA, Angbazo D.

West Afr J Med. 2005 Oct-Dec;24(4):305-8.

PMID:
16483045
[PubMed - indexed for MEDLINE]
16.

Lipoprotein profiles and serum peroxide levels of aged women consuming palmolein or oleic acid-rich sunflower oil diets.

Cuesta C, Ródenas S, Merinero MC, Rodríguez-Gil S, Sánchez-Muniz FJ.

Eur J Clin Nutr. 1998 Sep;52(9):675-83.

PMID:
9756125
[PubMed - indexed for MEDLINE]
17.

The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.

Misra M, Webb AT, Reaveley DA, Doherty E, O'Donnell M, Seed M, Brown EA.

Adv Perit Dial. 1997;13:168-73.

PMID:
9360675
[PubMed - indexed for MEDLINE]
18.

The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.

Pennell P, Leclercq B, Delahunty MI, Walters BA.

Clin Nephrol. 2006 Nov;66(5):336-47.

PMID:
17140163
[PubMed - indexed for MEDLINE]
19.

Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men.

Almendingen K, Jordal O, Kierulf P, Sandstad B, Pedersen JI.

J Lipid Res. 1995 Jun;36(6):1370-84.

PMID:
7666013
[PubMed - indexed for MEDLINE]
Free Article
20.

Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.

Halle M, Berg A, Baumstark MW, König D, Huonker M, Keul Joseph.

Atherosclerosis. 1999 Mar;143(1):185-92.

PMID:
10208494
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk